Peacekeeping Engineered T Cells Restore the Balance in Diabetes

For patients with type 1 diabetes, hope is around the corner with a new experimental therapy that uses genetically modified immune cells. Scientists at the Seattle Children’s Research Institute’s Center for Immunity and Immunotherapies have been granted a multi-million dollar research grant to accelerate the therapy’s path to the clinic.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.